In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end-to-end biologics CDMO Mabion have entered into a strategic development and manufacturing partnership with London based NovalGen an existing client with whom cooperation under CDMO orders was first disclosed in current report No. 13/2024 dated August 16, 2024. […]
Post Type Archives: News
Sequoia Biotech Consulting Rebrands as Syner-G BioPharma Group
Sequoia Biotech Consulting has officially rebranded as Syner-G BioPharma Group, marking a unified identity that reflects an expanded set of capabilities and a deeper commitment to supporting biopharmaceutical innovation. Now operating as Syner-G BioPharma Group, the organization brings together a team of 400+ experts across North America and India, delivering integrated product development, regulatory strategy […]
Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the recent execution of agreements for the production of AD04 (0.33 mg ondansetron tablets), supporting both the completion of upcoming clinical trials and the planned New Drug Application (NDA) submission to the […]
Veranova Devens Site Breaks Ground on ADC Facility Expansion
Government officials, industry leaders, and local business representatives gathered yesterday to mark the groundbreaking of Veranova’s latest expansion at its Devens, Massachusetts facility. First announced in June 2024, the investment will add 9,000 square feet to the site, including a new state-of-the-art process development laboratory and two current Good Manufacturing Practice (cGMP) suites. These new […]
NANOFORM SECURES €5 MILLION R&D LOAN FROM BUSINESS FINLAND TO ADVANCE CLINICAL DEVELOPMENT OF NANOAPALUTAMIDE
Nanoform Finland Plc, a leading nanoparticle medicine performance-enhancing company, is pleased to announce that Business Finland has approved a €5 million research and development loan to support the clinical development of nanoapalutamide, Nanoform’s proprietary nanocrystalline formulation of apalutamide. “We are grateful for Business Finland’s continued support and confidence in our technology and vision”, said Prof. […]
Symbiosis Expands Global Reach with Key Appointment of Angelika Rublack as Senior Business Development Manager
Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in sterile manufacture of injectable drug products, has appointed Angelika Rublack as Senior Business Development Manager to support its expanding global client base and drive growth across several territories. With 25 years of international sales and key account experience, the last 16 of which […]
CELLforCURE by SEQENS to Manufacture Galapagos’ CAR T-Cell Therapy Candidates for Upcoming Trials, Expanding Decentralized Network in Paris and the Broader France Region
CELLforCURE by SEQENS, a leading Contract Development and Manufacturing Organization (CDMO) specialized in Advanced Therapy Medicinal Products (ATMPs), is pleased to announce a strategic partnership with Galapagos NV (Euronext & NASDAQ: GLPG) to support the decentralized manufacturing for clinical development of Galapagos’ CD19 CAR T-cell therapy candidate, GLPG5101, investigated in multiple relapsed/refractory non-Hodgkin lymphoma (NHL) […]
Aragen biomanufacturing site completes qualification with first GMP batches in July 2025
Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from July 2025. Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L. […]
Kindeva joins forces with Rocket Science Health to pioneer new Intranasal Delivery Platform
Kindeva, a global CDMO and drug delivery expert, and Rocket Science Health (RSH), a Canadian technology healthcare company, have joined forces to find partners to develop a new intranasal delivery platform. RSH’s cutting-edge technology, combined with Kindeva’s CDMO capabilities, will supercharge the product journey as RSH prepares for commercial readiness. The non-exclusive agreement will see […]
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of Kieron Wesson, PhD as Vice President, Head of Chemistry Manufacturing Controls (CMC), effective immediately. “I am pleased to welcome Kieron to Aligos,” said Sushmita Chanda, PhD, DABT, […]